Meet Our Global Board

The honorary board was formed by early supporters of the initiative. We now seek scientists from all countries and organizations to strengthen this global effort.

Presidency

Dr. José Emílio Fehr Pereira Lopes

President, MD, PhD, JD Founder, Chief Scientific Officer

Dr. José Alexandre Marzagão Barbuto

Vice President, MD, PhD

Directors

Dra. Judith Marie Faunce Garcia

Financial Director, PhD NASA – Former Astronaut

Dra. Ana Carolina Bariviera Barros

Director Secretary, Columbia University

Vinicius Valverde

Communication & Marketing Director

Board

Phellipe Amaral

Chief Scientific Officer in new medications in Labmass

Nailton Nascimento

PhD CMC Advisor

Marcos N. Eberlin

PhD Chemistry Advisor

Otavio Cabral Marques

PhD Scientific Advisor

Guilherme Gibertoni Anselmo

International Legal Affairs

Dr. João Falcão Dias

International Legal Adviser

Gabriel Liguori

MD, PhD, Switzerland

Nilton Soares Camilo Engles

Scientists in targeting delivering drug

Guido Moll

Scientist in development of individual cancer imunoterapy through AI, Berlin, Germany

Fernando T Kreutz

MD, PhD, Creator of the prostate cancer vaccine – Miami Cellvax

Camila Salviano

Marketing and Funding Expert – former St. Jude Hospital

Dr. Gustavo Henrique Goulart Trossini

PhD specialist in drug development, medicinal and computational chemistry, molecular modeling, and QSAR

Elias Tessaro

Researcher in development of new pharmaco into the GLP pattern nationwide

Dr. Alessandro Ulrich

Agronomy Engendering in the study of carcinogesis pesticides

A Global Effort

Our board brings together top researchers, medical experts, and pioneers from around the world—each dedicated to advancing revolutionary cancer treatments.

With members from Argentina, Brazil, Switzerland, the United States, and beyond, we are harnessing the power of international collaboration to change the future of cancer treatment.

From groundbreaking therapeutic cancer vaccines to cutting-edge immunotherapy, our experts are shaping the next era of cancer research.